早期研究发现,GLP-1类药物,如Ozempic,通过减缓酒精吸收速度,可以降低醉酒程度。 GLP-1 drugs like Ozempic may reduce drunkenness by slowing alcohol absorption, early study finds.

Virginia Tech研究人员进行的一项试点研究表明,GLP-1类药物,如Ozempic和Wegovy,可以通过减缓酒精吸收速度,减少酒精消费量,从而减少中毒。 A pilot study by Virginia Tech researchers suggests that GLP-1 drugs like Ozempic and Wegovy may help reduce alcohol consumption by slowing alcohol absorption, leading to reduced intoxication. 尽管饮用了类似的酒精饮料,但服用西马格卢提德,提泽帕提德或利拉格卢提德的参与者呼吸中酒精含量增加速度较慢,并且在饮用标准饮料后,他们表示感觉不那么醉. Participants taking semaglutide, tirzepatide, or liraglutide showed slower increases in breath alcohol levels and reported feeling less drunk after consuming a standard drink, despite similar alcohol intake. 其影响很可能是由于药物能推迟胃空荡。 The effect is likely due to the drugs’ ability to delay gastric emptying. 这些调查结果以20名肥胖成人为基础,支持早先的传闻报告,并指出了减少酒精使用的潜在新的物理机制,尽管需要进行更多的试验。 The findings, based on 20 adults with obesity, support earlier anecdotal reports and point to a potential new physical mechanism for reducing alcohol use, though larger trials are needed.